NCT06820021 Strength-based Tailored-Exercise Program at Home for Geriatric Patients
| NCT ID | NCT06820021 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Frailty |
| Study Type | INTERVENTIONAL |
| Enrollment | 256 participants |
| Start Date | 2025-05-23 |
| Primary Completion | 2028-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 256 participants in total. It began in 2025-05-23 with a primary completion date of 2028-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study focuses on the "Strength-based Tailored-Exercise Program at Home (STEP@Home)" aimed at improving health outcomes for geriatric patients at risk of hospitalization-associated functional decline. It is a sequential mixed-method study that combines quantitative and qualitative approaches.
Eligibility Criteria
Inclusion Criteria: * i) aged 60 or above * ii) has an acute hospitalization and the length of hospital stay is of ≥ 2 days2, * iii) has risk of functional decline in 3 months following hospitalization as measured by the Screening for High-Risk Patients (SHERPA) score of \>3.5. SHERPA is a brief measure to identify the high risk by screening for the risk factors, including old age, poor health perception, IADL dysfunction, mild cognitive impairment and fall in the previous year. * iv) discharged home without any referral for exercise-based rehabilitation * v) has a Smartphone to access video calls * vi) consented to participate. Exclusion Criteria: * i) admitted with a disabling condition leading to significant functional loss such as stroke,) * ii) bed-bound or chair bound * iii) with conditions contradictory to exercise training (e.g., acute muscular-skeletal problem, acute and unstable cardio-respiratory disease, etc), * iv) engaging in moderate or vigorous exercise (\>60min/week) in the past 6 months.
Contact & Investigator
Doris Sau Fung YU, PhD
PRINCIPAL INVESTIGATOR
The University of Hong Kong
Frequently Asked Questions
Who can join the NCT06820021 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Frailty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06820021 currently recruiting?
Yes, NCT06820021 is actively recruiting participants. Contact the research team at dyu1@hku.hk for enrollment information.
Where is the NCT06820021 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06820021 clinical trial?
NCT06820021 is sponsored by The University of Hong Kong. The principal investigator is Doris Sau Fung YU, PhD at The University of Hong Kong. The trial plans to enroll 256 participants.